Table 3.
Univariate and Multivariate Cox Proportional Analyses of Prognostic Factors Associated with Overall Survival in NSCLC Patients
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Age, ≥55 vs <55 | 1.012 (0.865–1.341) | 0.375 | ||
| Sex, male vs female | 0.996 (0.812–1.274) | 0.192 | ||
| Smoking status, smoker vs non-smoker | 1.546 (0.723–2.294) | 0.174 | ||
| Histology | ||||
| Adenocarcinoma vs squamous cell carcinoma | 1.002 (0.972–1.154) | 0.485 | ||
| Adenocarcinoma vs large cell carcinoma | 1.007 (0.956–1.294) | 0.574 | ||
| TNM stage, II vs I | 2.964 (1.432–3.741) | 0.001* | 2.673 (1.312–3.432) | 0.005* |
| Tumor size, ≥3 vs <3 | 1.874 (0.854–2.245) | 0.107 | ||
| Lymph node metastasis, yes vs no | 2.674 (1.374–3.674) | 0.002* | 2.431 (1.274–3.362) | 0.001* |
| SLC9A3-AS1 expression, high vs low | 1.645 (1.203–2.312) | 0.005* | 1.412 (1.102–1.994) | 0.029* |
Note: *P <0.05.
Abbreviations: NSCLC, non-small-cell lung cancer; HR, hazard ratio; CI, confidence interval.